CHICAGO, Aug. 19, 2025 (GLOBE NEWSWIRE) — COUR Pharma, a clinical-stage biotechnology company developing ï¬rst-in-class, disease-modifying therapies to treat autoimmune diseases, today announced that the first patient has been dosed in the Phase 1b/2a clinical trial for CNP-103, a tolerogenic nanoparticle therapy in development to address the underlying autoimmunity associated with type 1 diabetes (T1D). […]

BOSTON, Aug. 19, 2025 (GLOBE NEWSWIRE) — Imbria Pharmaceuticals, Inc., (“Imbria”), a clinical-stage company revolutionizing cardiovascular disease treatment by targeting cardiac energy metabolism, today announced the appointment of physician-scientist, Albert M. Kim, MD, PhD, FACC, FHRS, as Chief Medical Officer to drive clinical development of ninerafaxstat, a novel and differentiated therapy with broad potential across

NEW YORK and CAMBRIDGE, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) — Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation Janus Kinase (JAK) inhibitors for patients with myeloproliferative neoplasms, today announced the appointment of David Waller, PhD, as Senior Vice President and Head of Chemistry, Manufacturing and Controls (CMC). Dr. Waller brings more than 13

LAS VEGAS, Aug. 19, 2025 (GLOBE NEWSWIRE) — AdOmni, the leading AI-powered programmatic Digital-Out-of-Home (DOOH) and video advertising platform, today announced groundbreaking enhancements to its platform that enables self-service DOOH campaigns to be planned and bought as easily as Facebook or Instagram ad campaigns. These new features, powered by its proprietary AI assistant, Jeen AI,

(NASDAQ:SGRP), AUBURN HILLS, Mich., Aug. 19, 2025 (GLOBE NEWSWIRE) — SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR,” “SPAR Group” or the “Company”) a leading provider of merchandising, marketing, and distribution services, today announced that management will participate in the 16th Annual Midwest IDEAS Investor Conference at The InterContinental Chicago Magnificent Mile on August 27, 2025. The

NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) — Epiq today announced a strategic partnership with IRIS, a Canon company, to transform how organizations convert documents into actionable knowledge and business insights. IRIS brings advanced AI and machine learning capabilities that power intelligent content classification, data extraction, and seamless workflow automation. Integrating with the Epiq intelligent

(NASDAQ:RNTX), AUSTIN, Aug. 19, 2025 (GLOBE NEWSWIRE) — Rein Therapeutics (“Rein”) (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the Company to initiate its Phase

New platform fuses human expertise, robust data, and the computing power of AI to enhance quality, agility, and the innovation needed to engineer breakthrough value MORRISTOWN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) — Today, Lumanity has introduced its proprietary Expert-Directed Applied Intelligence (EDAI) platform, designed to enhance decision-making in today's complex healthcare landscape. EDAI merges

(NasdaqGM:ZSPC), SAN JOSE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — zSpace, Inc. (NASDAQ: ZSPC), a leader in immersive augmented reality (AR) solutions for education, today announced zKnowTM, an intelligent AI assistant that instantly answers educator questions about zSpace's extensive library of immersive learning content and technical resources. Following the success of its award-winning Career Coach

Collaboration brings the Vineland-3 assessment directly into ATrack's clinical software, bringing greater accuracy and time savings to BCBA treatment planning. ATrack Solutions today announced the integration of the Vineland™-3 assessment tool directly within its clinical software platform. Working with global learning company Pearson, this new agreement makesATrack the only ABA software solution with native access